fomesafen has been researched along with bumetanide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Castañeda-Hernandez, G; Lawand, NB; Lin, Q; Valencia-de Ita, S; Willis, WD | 1 |
Banach, B; Mikołajek-Bedner, W; Sroczyński, T; Słuczanowska-Glabowska, S | 1 |
Andoh, T; Goto, T; Kamiya, Y; Koyama, Y; Mihara, T; Miyazaki, T; Morita, S; Uchimoto, K | 1 |
3 other study(ies) available for fomesafen and bumetanide
Article | Year |
---|---|
Role of the Na+-K+-2Cl- cotransporter in the development of capsaicin-induced neurogenic inflammation.
Topics: Animals; Bumetanide; Capsaicin; Ganglia, Spinal; Hyperalgesia; Inflammation; Male; Rats; Rats, Sprague-Dawley; Reflex; Sodium-Potassium-Chloride Symporters; Vasodilation | 2006 |
Ionic support of the cough reflex.
Topics: Amiloride; Animals; Bumetanide; Chlorides; Cough; Female; In Vitro Techniques; Ion Transport; Male; Membrane Potentials; Neurotransmitter Agents; Rabbits; Reflex; Respiratory Transport; Sodium; Sodium Channel Blockers; Sodium Potassium Chloride Symporter Inhibitors; Trachea | 2009 |
Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits γ-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats.
Topics: Aging; Animals; Animals, Newborn; Bumetanide; CA3 Region, Hippocampal; Calcium; Calcium Signaling; Cyclic AMP Response Element-Binding Protein; Diuretics; Drug Synergism; GABA Antagonists; gamma-Aminobutyric Acid; Hypnotics and Sedatives; Midazolam; Rats; Rats, Sprague-Dawley; Reflex; Solute Carrier Family 12, Member 2; Up-Regulation | 2013 |